{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:44:17Z","timestamp":1790837057292,"version":"4.1.0"},"reference-count":72,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A hypercoagulable state, chronic inflammation, and increased risk of venous thrombosis and stroke are prominent features in patients with sickle cell disease (SCD). Coagulation factor XII (FXII) triggers activation of the contact system that is known to be involved in both thrombosis and inflammation, but not in physiological hemostasis. Therefore, we investigated whether FXII contributes to the prothrombotic and inflammatory complications associated with SCD. We found that when compared with healthy controls, patients with SCD exhibit increased circulating biomarkers of FXII activation that are associated with increased activation of the contact pathway. We also found that FXII, but not tissue factor, contributes to enhanced thrombin generation and systemic inflammation observed in sickle cell mice challenged with tumor necrosis factor \u03b1. In addition, FXII inhibition significantly reduced experimental venous thrombosis, congestion, and microvascular stasis in a mouse model of SCD. Moreover, inhibition of FXII attenuated brain damage and reduced neutrophil adhesion to the brain vasculature of sickle cell mice after ischemia\/reperfusion induced by transient middle cerebral artery occlusion. Finally, we found higher FXII, urokinase plasminogen activator receptor, and \u03b1M\u03b22 integrin expression in neutrophils of patients with SCD compared with healthy controls. Our data indicate that targeting FXII effectively reduces experimental thromboinflammation and vascular complications in a mouse model of SCD, suggesting that FXII inhibition may provide a safe approach for interference with inflammation, thrombotic complications, and vaso-occlusion in patients with SCD.<\/jats:p>","DOI":"10.1182\/blood.2022017074","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T21:07:59Z","timestamp":1674853679000},"page":"1871-1883","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":38,"title":["Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease"],"prefix":"10.1182","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5529-7847","authenticated-orcid":false,"given":"Erica M.","family":"Sparkenbaugh","sequence":"first","affiliation":[{"name":"1Division of Hematology and Blood Research Center, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9098-3853","authenticated-orcid":false,"given":"Michael W.","family":"Henderson","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Blood Research Center, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Miller-Awe","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Blood Research Center, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6296-3844","authenticated-orcid":false,"given":"Christina","family":"Abrams","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Blood Research Center, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7669-0760","authenticated-orcid":false,"given":"Anton","family":"Ilich","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Blood Research Center, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8722-838X","authenticated-orcid":false,"given":"Fatima","family":"Trebak","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Blood Research Center, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9765-6895","authenticated-orcid":false,"given":"Nirupama","family":"Ramadas","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Blood Research Center, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantel","family":"Vital","sequence":"additional","affiliation":[{"name":"2Louisiana State University Health Sciences Center, Shreveport, LA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9590-3063","authenticated-orcid":false,"given":"Dillon","family":"Bohinc","sequence":"additional","affiliation":[{"name":"3Hematology and Oncology Division, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara L.","family":"Bane","sequence":"additional","affiliation":[{"name":"3Hematology and Oncology Division, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunsheng","family":"Chen","sequence":"additional","affiliation":[{"name":"4Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margi","family":"Patel","sequence":"additional","affiliation":[{"name":"5Division of Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7133-795X","authenticated-orcid":false,"given":"Michael","family":"Wallisch","sequence":"additional","affiliation":[{"name":"6Aronora Inc, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4594-5975","authenticated-orcid":false,"given":"Thomas","family":"Renn\u00e9","sequence":"additional","affiliation":[{"name":"7Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"},{"name":"8Center for Thrombosis and Hemostasis, Johannes Gutenberg University Medical Center, Mainz, Germany"},{"name":"9Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6212-2247","authenticated-orcid":false,"given":"Andras","family":"Gruber","sequence":"additional","affiliation":[{"name":"6Aronora Inc, Portland, OR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Cooley","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Blood Research Center, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8142-8014","authenticated-orcid":false,"given":"David","family":"Gailani","sequence":"additional","affiliation":[{"name":"10Vanderbilt University Medical Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3345-1580","authenticated-orcid":false,"given":"Malgorzata","family":"Kasztan","sequence":"additional","affiliation":[{"name":"5Division of Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1324-0831","authenticated-orcid":false,"given":"Gregory M.","family":"Vercellotti","sequence":"additional","affiliation":[{"name":"4Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Belcher","sequence":"additional","affiliation":[{"name":"4Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7008-5423","authenticated-orcid":false,"given":"Felicity E.","family":"Gavins","sequence":"additional","affiliation":[{"name":"11Department of Life Sciences, Centre for Inflammation Research and Translational Medicine, Brunel University London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6075-7609","authenticated-orcid":false,"given":"Evi X.","family":"Stavrou","sequence":"additional","affiliation":[{"name":"3Hematology and Oncology Division, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH"},{"name":"12Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH"},{"name":"13Department of Medicine, Section of Hematology-Oncology, Louis Stokes Veterans Administration Medical Center, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8930-4304","authenticated-orcid":false,"given":"Nigel S.","family":"Key","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Blood Research Center, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5162-7135","authenticated-orcid":false,"given":"Rafal","family":"Pawlinski","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Blood Research Center, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2023110217212730700_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10739680490278402","article-title":"The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy","volume":"11","author":"Hebbel","year":"2004","journal-title":"Microcirculation"},{"key":"2023110217212730700_bib2","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"2023110217212730700_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2022.10233","article-title":"Sickle cell disease: a review","volume":"328","author":"Kavanagh","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"2023110217212730700_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjh.12336","article-title":"Interplay between coagulation and vascular inflammation in sickle cell disease","volume":"162","author":"Sparkenbaugh","year":"2013","journal-title":"Br J Haematol"},{"issue":"5","key":"2023110217212730700_bib5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjmed.2012.12.016","article-title":"Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication","volume":"126","author":"Naik","year":"2013","journal-title":"Am J Med"},{"issue":"15","key":"2023110217212730700_bib6","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.3390\/ijms21155279","article-title":"Sickle cell disease: a paradigm for venous thrombosis pathophysiology","volume":"21","author":"Lizarralde-Iragorri","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"22","key":"2023110217212730700_bib7","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1182\/blood-2014-09-551564","article-title":"How I treat and manage strokes in sickle cell disease","volume":"125","author":"Kassim","year":"2015","journal-title":"Blood"},{"issue":"11","key":"2023110217212730700_bib8","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood-2013-08-523936","article-title":"Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease","volume":"123","author":"Sparkenbaugh","year":"2014","journal-title":"Blood"},{"issue":"3","key":"2023110217212730700_bib9","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood-2012-04-424143","article-title":"Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease","volume":"120","author":"Chantrathammachart","year":"2012","journal-title":"Blood"},{"issue":"10","key":"2023110217212730700_bib10","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1182\/blood-2015-11-681114","article-title":"Thrombin-independent contribution of tissue factor to inflammation and cardiac hypertrophy in a mouse model of sickle cell disease","volume":"127","author":"Sparkenbaugh","year":"2016","journal-title":"Blood"},{"issue":"15","key":"2023110217212730700_bib11","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1182\/blood-2015-01-625707","article-title":"Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice","volume":"126","author":"Arumugam","year":"2015","journal-title":"Blood"},{"issue":"20","key":"2023110217212730700_bib12","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1182\/blood.2019003543","article-title":"Thrombin-mediated activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell disease","volume":"135","author":"Sparkenbaugh","year":"2020","journal-title":"Blood"},{"issue":"1","key":"2023110217212730700_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/ATVBAHA.116.308595","article-title":"Factor XII as a therapeutic target in thromboembolic and inflammatory diseases","volume":"37","author":"Nickel","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"17","key":"2023110217212730700_bib14","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2017-04-569111","article-title":"Coagulation factor XII in thrombosis and inflammation","volume":"131","author":"Maas","year":"2018","journal-title":"Blood"},{"issue":"3","key":"2023110217212730700_bib15","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1172\/JCI92880","article-title":"Factor XII and uPAR upregulate neutrophil functions to influence wound healing","volume":"128","author":"Stavrou","year":"2018","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"2023110217212730700_bib16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/rth2.12235","article-title":"Factor XII - what's important but not commonly thought about","volume":"3","author":"Schmaier","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"issue":"22","key":"2023110217212730700_bib17","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1182\/blood-2012-07-292094","article-title":"In\u00a0vivo roles of factor XII","volume":"120","author":"Renne","year":"2012","journal-title":"Blood"},{"issue":"3","key":"2023110217212730700_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0022-3476(85)80669-7","article-title":"Reduction of contact factors in sickle cell disease","volume":"106","author":"Gordon","year":"1985","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"2023110217212730700_bib19","first-page":"313","article-title":"Reduced plasma kininogen concentration during sickle cell crisis","volume":"41","author":"Verma","year":"1983","journal-title":"Res Commun Chem Pathol Pharmacol"},{"issue":"6","key":"2023110217212730700_bib20","first-page":"551","article-title":"Studies of the kallikrein-kinin system in patients with sickle cell anemia","volume":"75","author":"Miller","year":"1983","journal-title":"J\u00a0Natl Med Assoc"},{"issue":"9","key":"2023110217212730700_bib21","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/jth.14972","article-title":"High molecular weight kininogen contributes to early mortality and kidney dysfunction in a mouse model of sickle cell disease","volume":"18","author":"Sparkenbaugh","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"2023110217212730700_bib22","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1182\/blood-2006-02-004812","article-title":"Correction of sickle cell disease by homologous recombination in embryonic stem cells","volume":"108","author":"Wu","year":"2006","journal-title":"Blood"},{"issue":"5339","key":"2023110217212730700_bib23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1126\/science.278.5339.873","article-title":"Knockout-transgenic mouse model of sickle cell disease","volume":"278","author":"Ryan","year":"1997","journal-title":"Science"},{"issue":"5","key":"2023110217212730700_bib24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/rth2.12389","article-title":"Protease: serpin complexes to assess contact system and intrinsic pathway activation","volume":"4","author":"Henderson","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"issue":"11","key":"2023110217212730700_bib25","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/bloodadvances.2021006620","article-title":"Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19","volume":"6","author":"Henderson","year":"2022","journal-title":"Blood Adv"},{"issue":"24","key":"2023110217212730700_bib26","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2013-10-529982","article-title":"Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease","volume":"123","author":"Chen","year":"2014","journal-title":"Blood"},{"issue":"4","key":"2023110217212730700_bib27","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nm.1939","article-title":"Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury","volume":"15","author":"Hidalgo","year":"2009","journal-title":"Nat Med"},{"issue":"5","key":"2023110217212730700_bib28","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1538-7836.2005.01253.x","article-title":"A\u00a0monoclonal antibody that inhibits mouse tissue factor function","volume":"3","author":"Kirchhofer","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"issue":"20","key":"2023110217212730700_bib29","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1182\/blood.2019003543","article-title":"Thrombin activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell disease","volume":"135","author":"Sparkenbaugh","year":"2020","journal-title":"Blood"},{"key":"2023110217212730700_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2022.06.018","article-title":"MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease","volume":"249","author":"Belcher","year":"2022","journal-title":"Transl Res"},{"issue":"2","key":"2023110217212730700_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12195-020-00657-6","article-title":"Development of coagulation factor XII antibodies for inhibiting vascular device-related thrombosis","volume":"14","author":"Kohs","year":"2021","journal-title":"Cell Mol Bioeng"},{"issue":"23","key":"2023110217212730700_bib32","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1182\/blood.2019000424","article-title":"Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease","volume":"133","author":"Faes","year":"2019","journal-title":"Blood"},{"issue":"11","key":"2023110217212730700_bib33","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1111\/jth.15037","article-title":"Model-dependent contributions of FXII and FXI to venous thrombosis in mice","volume":"18","author":"Grover","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"11","key":"2023110217212730700_bib34","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1182\/blood-2013-04-499111","article-title":"Factor XII inhibition reduces thrombus formation in a primate thrombosis model","volume":"123","author":"Matafonov","year":"2014","journal-title":"Blood"},{"issue":"3","key":"2023110217212730700_bib35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1084\/jem.20052458","article-title":"Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis","volume":"203","author":"Kleinschnitz","year":"2006","journal-title":"J\u00a0Exp Med"},{"issue":"52","key":"2023110217212730700_bib36","doi-asserted-by":"crossref","first-page":"19678","DOI":"10.1073\/pnas.0603873103","article-title":"Why molecules move along a temperature gradient","volume":"103","author":"Duhr","year":"2006","journal-title":"Proc Natl Acad Sci U\u00a0S A"},{"issue":"3","key":"2023110217212730700_bib37","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ymeth.2012.12.005","article-title":"Microscale thermophoresis quantifies biomolecular interactions under previously challenging conditions","volume":"59","author":"Seidel","year":"2013","journal-title":"Methods"},{"issue":"3","key":"2023110217212730700_bib38","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.thromres.2009.11.028","article-title":"Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis","volume":"125","author":"Stavrou","year":"2010","journal-title":"Thromb Res"},{"issue":"5","key":"2023110217212730700_bib39","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/MOH.0000000000000450","article-title":"Factor XII in inflammation and wound healing","volume":"25","author":"Stavrou","year":"2018","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"2023110217212730700_bib40","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2014810118","article-title":"Kallikrein directly interacts with and activates factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI","volume":"118","author":"Kearney","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2023110217212730700_bib41","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1182\/blood.2019001643","article-title":"Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathways","volume":"135","author":"Noubouossie","year":"2020","journal-title":"Blood"},{"issue":"1","key":"2023110217212730700_bib42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/ATVBAHA.119.313503","article-title":"Plasma kallikrein contributes to coagulation in the absence of factor XI by activating factor IX","volume":"40","author":"Visser","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"2023110217212730700_bib43","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.exphem.2016.06.252","article-title":"Targeting Mac-1-mediated leukocyte-RBC interactions uncouples the benefits for acute vaso-occlusion and chronic organ damage","volume":"44","author":"Chen","year":"2016","journal-title":"Exp Hematol"},{"issue":"34","key":"2023110217212730700_bib44","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2207592119","article-title":"Endothelial VWF is critical for the pathogenesis of vaso-occlusive episode in a mouse model of sickle cell disease","volume":"119","author":"Shi","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2023110217212730700_bib45","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","article-title":"Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease","volume":"123","author":"Belcher","year":"2014","journal-title":"Blood"},{"issue":"11","key":"2023110217212730700_bib46","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3324\/haematol.2009.008938","article-title":"Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease","volume":"94","author":"van Beers","year":"2009","journal-title":"Haematologica"},{"issue":"6","key":"2023110217212730700_bib47","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1160\/TH11-10-0689","article-title":"The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles","volume":"107","author":"Gerotziafas","year":"2012","journal-title":"Thromb Haemost"},{"issue":"8","key":"2023110217212730700_bib48","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2016-06-722298","article-title":"In\u00a0vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps","volume":"129","author":"Noubouossie","year":"2017","journal-title":"Blood"},{"key":"2023110217212730700_bib49","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3389\/fimmu.2017.01115","article-title":"Factor XII-driven inflammatory reactions with implications for anaphylaxis","volume":"8","author":"Bender","year":"2017","journal-title":"Front Immunol"},{"issue":"2","key":"2023110217212730700_bib50","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.immuni.2011.02.008","article-title":"Mast cells increase vascular permeability by heparin-initiated bradykinin formation in\u00a0vivo","volume":"34","author":"Oschatz","year":"2011","journal-title":"Immunity"},{"issue":"17","key":"2023110217212730700_bib51","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1182\/blood-2018-03-822593","article-title":"How I diagnose and treat venous thromboembolism in sickle cell disease","volume":"132","author":"Shet","year":"2018","journal-title":"Blood"},{"issue":"2","key":"2023110217212730700_bib52","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/bjh.14655","article-title":"Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality","volume":"178","author":"Brunson","year":"2017","journal-title":"Br J Haematol"},{"issue":"16","key":"2023110217212730700_bib53","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood-2017-03-745349","article-title":"Red blood cells in thrombosis","volume":"130","author":"Byrnes","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2023110217212730700_bib54","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/jth.14360","article-title":"Red blood cells: the forgotten player in hemostasis and thrombosis","volume":"17","author":"Weisel","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"issue":"18","key":"2023110217212730700_bib55","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1182\/blood-2016-10-746479","article-title":"Elevated hematocrit enhances platelet accumulation following vascular injury","volume":"129","author":"Walton","year":"2017","journal-title":"Blood"},{"issue":"8","key":"2023110217212730700_bib56","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1111\/jth.15407","article-title":"Pathologically stiff erythrocytes impede contraction of blood clots","volume":"19","author":"Tutwiler","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"2023110217212730700_bib57","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1182\/bloodadvances.2019000940","article-title":"Bleeding in patients with sickle cell disease: a population-based study","volume":"4","author":"Hariharan","year":"2020","journal-title":"Blood Adv"},{"issue":"19","key":"2023110217212730700_bib58","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1182\/blood-2010-02-270918","article-title":"A\u00a0role for factor XIIa-mediated factor XI activation in thrombus formation in\u00a0vivo","volume":"116","author":"Cheng","year":"2010","journal-title":"Blood"},{"issue":"222","key":"2023110217212730700_bib59","doi-asserted-by":"crossref","first-page":"222ra217","DOI":"10.1126\/scitranslmed.3006804","article-title":"A\u00a0factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk","volume":"6","author":"Larsson","year":"2014","journal-title":"Sci Transl Med"},{"key":"2023110217212730700_bib60","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.thromres.2016.02.020","article-title":"A\u00a0comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation","volume":"140","author":"Kokoye","year":"2016","journal-title":"Thromb Res"},{"issue":"2","key":"2023110217212730700_bib61","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.20050664","article-title":"Defective thrombus formation in mice lacking coagulation factor XII","volume":"202","author":"Renne","year":"2005","journal-title":"J\u00a0Exp Med"},{"issue":"14","key":"2023110217212730700_bib62","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1182\/blood-2011-03-339572","article-title":"Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin","volume":"118","author":"Konings","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2023110217212730700_bib63","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.thromres.2015.06.028","article-title":"The role of activated coagulation factor XII in overall clot stability and fibrinolysis","volume":"136","author":"Konings","year":"2015","journal-title":"Thromb Res"},{"issue":"1","key":"2023110217212730700_bib64","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ajh.23586","article-title":"Frequent red cell transfusions reduced vascular endothelial activation and thrombogenicity in children with sickle cell anemia and high stroke risk","volume":"89","author":"Hyacinth","year":"2014","journal-title":"Am J Hematol"},{"issue":"10","key":"2023110217212730700_bib65","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1161\/STROKEAHA.113.001312","article-title":"Toward a stroke-free childhood in sickle cell disease: the 2013 Sherman Lecture","volume":"44","author":"Adams","year":"2013","journal-title":"Stroke"},{"issue":"4","key":"2023110217212730700_bib66","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1016\/j.neuroimage.2009.11.061","article-title":"Enhanced cortical reperfusion protects coagulation factor XII-deficient mice from\u00a0ischemic stroke as revealed by high-field\u00a0MRI","volume":"49","author":"Pham","year":"2010","journal-title":"Neuroimage"},{"issue":"15","key":"2023110217212730700_bib67","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1182\/blood-2010-08-301366","article-title":"Mechanisms of enhanced thrombus formation in cerebral microvessels of mice expressing hemoglobin-S","volume":"117","author":"Gavins","year":"2011","journal-title":"Blood"},{"issue":"11","key":"2023110217212730700_bib68","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood.2020009166","article-title":"Targeting the AnxA1\/Fpr2\/ALX pathway regulates neutrophil function, promoting thromboinflammation resolution in sickle cell disease","volume":"137","author":"Ansari","year":"2021","journal-title":"Blood"},{"issue":"11","key":"2023110217212730700_bib69","doi-asserted-by":"crossref","first-page":"e86663","DOI":"10.1172\/jci.insight.86663","article-title":"Protective and detrimental effects of neuroectodermal cell-derived tissue factor in mouse models of stroke","volume":"1","author":"Wang","year":"2016","journal-title":"JCI Insight"},{"issue":"1","key":"2023110217212730700_bib70","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000468994","article-title":"Factor XII as a risk marker for hemorrhagic stroke: a prospective cohort study","volume":"7","author":"Johansson","year":"2017","journal-title":"Cerebrovasc Dis Extra"},{"issue":"3","key":"2023110217212730700_bib71","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s12975-012-0186-5","article-title":"Inhibition of factor XII-mediated activation of factor XI provides protection against experimental acute ischemic stroke in mice","volume":"3","author":"Leung","year":"2012","journal-title":"Transl Stroke Res"},{"issue":"4","key":"2023110217212730700_bib72","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/CIRCULATIONAHA.118.039345","article-title":"Novel role for the AnxA1-Fpr2\/ALX signaling axis as a key regulator of platelet function to promote resolution of inflammation","volume":"140","author":"Senchenkova","year":"2019","journal-title":"Circulation"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/141\/15\/1871\/2087409\/blood_bld-2022-017074-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/141\/15\/1871\/2087409\/blood_bld-2022-017074-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T17:22:59Z","timestamp":1698945779000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/141\/15\/1871\/494268\/Factor-XII-contributes-to-thrombotic-complications"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":72,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023,4,13]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2022017074","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]}}}